logo dark logo light logo
  • Project
    • Project Summary
    • Objectives
    • Work Plan
    • Demo Cases
  • Partners
  • PHOENIX-OITB
  • Open Call
  • News & Media
  • Contact
logo dark logo light logo
  • Project
    • Project Summary
    • Objectives
    • Work Plan
    • Demo Cases
  • Partners
  • PHOENIX-OITB
  • Open Call
  • News & Media
  • Contact
Mobile Logo
  • Project
    • Project Summary
    • Objectives
    • Work Plan
    • Demo Cases
  • Partners
  • PHOENIX-OITB
  • Open Call
  • News & Media
  • Contact
Image Alt

Project Outcomes

July 18, 2025
Phoenix

Expert Interviews: Physico-Chemical Characterization

Read More
July 14, 2025
Phoenix

Videos: Simulations of nanoparticles

Read More
April 2, 2025
Phoenix

Joint OITB Interview with NextGenMicrofluidics

Read More
March 19, 2025
Phoenix

Oral formulation of nanocrystals: Interview with Demo Case partner MyBiotech

Read More
February 28, 2025
Phoenix

Topas particle conjugates coupled with tolerogenic peptide epitopes

Read More
January 16, 2025
Phoenix

NaDeNo Nanoscience AS becomes second PHOENIX Open Call recipient

Read More
March 12, 2024
Phoenix

Nanofaber srl. becomes first PHOENIX Open Call Recipient

Read More
March 11, 2024
Phoenix

Apply for the 2nd Round of the PHOENIX Open Call!

Read More
February 26, 2024
Phoenix

PHOENIX gGmbH founded to support innovation in nano-pharmaceutical development

Read More
January 24, 2022
Phoenix

PHOENIX flyer

Read More
  • 1
  • 2

Posts pagination

Previous 1 2

Contact us

MyBiotech GmbH
IndustriestraĂźe 1B
66802 Ăśberherrn
Germany
info@phoenix-oitb.eu

Join the PHOENIX community!

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 953110.

 

Downloads  |  Legal Notice  |  Privacy Policy